GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

Transcription

1 GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review

2 GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0) or reportstore@bioportfolio.com 2

3 GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better. The profile contains critical company information including: - Business description A detailed description of the company s operations and business divisions. - Corporate strategy Analyst s summarization of the company s business strategy. - SWOT Analysis A detailed analysis of the company s strengths, weakness, opportunities and threats. - Company history Progression of key events associated with the company. - Major products and services A list of major products, services and brands of the company. - Key competitors A list of key competitors to the company. - Key employees A list of the key executives of the company. - Executive biographies A brief summary of the executives employment history. - Key operational heads A list of personnel heading key departments/functions. - Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history. Highlights GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of HIV, respiratory, cancer, immuno-inflammation, anti-virals, central nervous system (CNS), metabolic, cardiovascular and urogenital, anti-bacterials, dermatology and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and gastro-intestinal diseases. GSK s vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in Brentford, Middlesex, the UK. 3

4 GlaxoSmithKline Plc Key Recent Developments Mar 23,2018: GSK Update Regarding Pfizer Consumer Healthcare Mar 19,2018: The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the Lab of the Future Mar 05,2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in the Triangle region of North Carolina Mar 05,2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in Greater Philadelphia region Feb 23,2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified Key benefits of buying this profile include: You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors. Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events. Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted. Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios. Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs. Note: Some sections may be missing if data is unavailable for the company Additional Details 4

5 Publisher : Global Data Reference : GDPH4279FSA Number of Pages : 83 Report Format : PDF Publisher Information : 5

6 Table Of Contents for GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review [Report Updated: ] Table of Contents Table of Contents 3List of Tables 5List of Figures 5Section 1 - About the Company 6GlaxoSmithKline Plc - Key Facts 6GlaxoSmithKline Plc - Key Employees 7GlaxoSmithKline Plc - Key Employee Biographies 8GlaxoSmithKline Plc - Major Products and Services 9GlaxoSmithKline Plc - History 12GlaxoSmithKline Plc - Company Statement 33GlaxoSmithKline Plc - Locations And Subsidiaries 35Head Office 35Other Locations & Subsidiaries 35Joint Venture 47Section 2 Company Analysis 49Company Overview 49GlaxoSmithKline Plc - Business Description 49Business Segment: Consumer Healthcare 49Overview 49Performance 49Key Stats 50Business Segment: Pharmaceuticals 50Overview 50Performance 50Key Stats 50Business Segment: Vaccines 50Overview 50Performance 51Key Stats 51Geographical Segment: International 51Performance 51Geographical Segment: The UK 51Performance 51Geographical Segment: US 51Performance 51R&D Overview 51GlaxoSmithKline Plc - Corporate Strategy 53GlaxoSmithKline Plc - SWOT Analysis 54SWOT Analysis - Overview 54GlaxoSmithKline Plc - Strengths 54GlaxoSmithKline Plc - Weaknesses 55GlaxoSmithKline Plc - Opportunities 56GlaxoSmithKline Plc - Threats 57GlaxoSmithKline Plc - Key Competitors 58Section 3 Company Financial Ratios 59Financial Ratios - Capital Market Ratios 59Financial Ratios - Annual Ratios 60Performance Chart 63Financial Performance 63Financial Ratios - Interim Ratios 64Financial Ratios - Ratio Charts 65Section 4 Company s Lifesciences Financial Deals and Alliances 66GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD GlaxoSmithKline Plc, Recent Deals Summary 68Section 5 Company s Recent Developments 69Mar 23, 2018: GSK Update Regarding Pfizer Consumer Healthcare 69Mar 19, 2018: The Pistoia Alliance Calls for Greater Life Sciences Collaboration to Build the Lab of the Future 70Mar 05, 2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in the Triangle region of North Carolina 71Mar 05, 2018: Local nonprofits make a bigger IMPACT with $40,000 award from GSK in Greater Philadelphia region 72Feb 23, 2018: GSK, Ministry of Economy, Trade and Industry "Superior Health and Good Management Act 2018 (White 500)" for 2 consecutive years certified 73Feb 20, 2018: Scientists find new antimalarial drug targets 74Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in Jan 11, 2018: A Novel Rapid Method Produces Superior Blood Stem Cells for Bone Marrow Transplantation 76Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice 77Dec 06, 2017: GSK welcomes launch of the UK Government s Life Sciences Sector Deal 78Section 6 Appendix 79Methodology 79Ratio Definitions 79About GlobalData 83Contact Us 83Disclaimer 83 6

7 List Of Tables in GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review [Report Updated: ] List of Tables GlaxoSmithKline Plc, Key Facts 6 GlaxoSmithKline Plc, Key Employees 7 GlaxoSmithKline Plc, Key Employee Biographies 8 GlaxoSmithKline Plc, Major Products and Services 9 GlaxoSmithKline Plc, History 12 GlaxoSmithKline Plc, Other Locations 35 GlaxoSmithKline Plc, Subsidiaries 35 GlaxoSmithKline Plc, Joint Venture 47 GlaxoSmithKline Plc, Key Competitors 58 GlaxoSmithKline Plc, Ratios based on current share price 59 GlaxoSmithKline Plc, Annual Ratios 60 GlaxoSmithKline Plc, Annual Ratios (Cont...1) 61 GlaxoSmithKline Plc, Annual Ratios (Cont...2) 62 GlaxoSmithKline Plc, Interim Ratios 64 GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD GlaxoSmithKline Plc, Recent Deals Summary 68 Currency Codes 79 Capital Market Ratios 79 Equity Ratios 80 Profitability Ratios 80 Cost Ratios 81 Liquidity Ratios 81 Leverage Ratios 82 Efficiency Ratios 82 7

8 List Of Figures, Charts and Diagrams in GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review [Report Updated: ] List of Figures GlaxoSmithKline Plc, Performance Chart ( ) 63 GlaxoSmithKline Plc, Ratio Charts 65 GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD GlaxoSmithKline Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD

9 How to Buy... GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review [Report Updated: ] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0) We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $125 Single User Price $250 Site License Price $375 Global License Price Payment Options: (please tick one) Online Credit Card (we will you the invoice with a payment link) Direct Wire Transfer (we will you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0) We will be delighted to give you our personal attention. 9